Page 47 - Interim Order News Today

Posted on 10423 Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), Appili Therapeutics (TSX: APLI, OTCQX: APLIF) and Global Response Aid FZCO (GRA) today announced that Dr. Reddy’s Canada has filed an application on behalf of the consortium for REEQONUS™ (favipiravir) Tablets for the acute treatment of mild to moderate COVID-19 adult pat...

Updated: Share Article AAA Dr. Reddy’s Laboratories Canada Inc., on behalf of a consortium, has filed an application with Health Canada seeking authorisation for Reeqonus (favipiravir) tablets for the acute treatment of mild to moderate COVID-19 adult patients. “Dr. Reddy’s is working closely with Health Canada for an expedited review of the drug application as speed to market is essential”, VP and general manager Vinod Ramachandran said. “If approved, it will launch the product soon ...

Dr Reddys labs, its subsidiaries announces filing application for REEQONUS™ (favipiravir) Tablets Hyderabad, Dec 22 (UNI) Dr. Reddy’s Laboratories Limited, along with its subsidiaries together referred to as “Dr. Reddy’s”, Appili Therapeutics and Global Response Aid FZCO (GRA) on Tuesday announced that Dr. Reddy’s Canada has filed an application on behalf of the consortium for REEQONUS™ (favipiravir) Tablets. The REEQONUS™ (favipiravir) Tablets was for the acute treatment of mi...

Representational image.   Dr. Reddys is working closely with Health Canada for an expedited review of the drug application, says Vinod Ramachandran, Vice President and General Manager, Dr. Reddy’s Laboratories Canada Inc Dr Reddys Laboratories Ltd, Canada-based Appili Therapeutics and Dubai-based Global Response Aid FZCO (GRA) on Tuesday said Dr Reddys Canada has filed an application on behalf of the consortium for Reeqonus (favipiravir) Tablets for treating COVID-19 in the North American c...

West Fraser and Norbord Announce Mailing of Circulars for Special Meetings of Shareholders News provided by Share this article Virtual shareholder meetings for both West Fraser and Norbord are scheduled for January 19, 2021 Interim order regarding the Arrangement received by Norbord from the Ontario Superior Court of Justice U.S. and German regulatory approvals received VANCOUVER, BC and TORONTO, ON, Dec. 21, 2020 /PRNewswire/ - West Fraser Timber Co. Ltd. (" West Fraser") (TSX: WFT) and Norbo...

Share this article Share this article NEW YORK, Dec. 17, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Sona Nanotech Inc. (OTC: SNANF) between July 2, 2020 and November 25, 2020, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Sona investors under the federal securities laws. To join the Sona class action, go http://www.rosenlegal.com/cases-register-19...

To print this article, all you need is to be registered or login on Mondaq.com. Weve heard politicians advocate importing "cheaper" prescription medical products from Canada for years.  Weve always thought the idea was ludicrous.  As we said, a little more than two years ago: Think about it.  California alone has a greater population than Canada.  Any large-scale importation of cheaper Canadian drugs to the United States would almost immediately cause shortages in Ca...

Latest updates on this topic.